CELANESE CORP (CE)

US1508701034 - Common Stock

75  +2.1 (+2.88%)

After market: 75 0 (0%)

Fundamental Rating

5

CE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. There are concerns on the financial health of CE while its profitability can be described as average. CE is valued quite cheap, while showing a decent growth score. This is a good combination! Finally CE also has an excellent dividend rating.



6

1. Profitability

1.1 Basic Checks

CE had positive earnings in the past year.
CE had a positive operating cash flow in the past year.
CE had positive earnings in each of the past 5 years.
CE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 7.46%, CE belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
CE has a better Return On Equity (26.86%) than 94.05% of its industry peers.
With a Return On Invested Capital value of 4.28%, CE perfoms like the industry average, outperforming 51.19% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CE is in line with the industry average of 6.50%.
Industry RankSector Rank
ROA 7.46%
ROE 26.86%
ROIC 4.28%
ROA(3y)10.12%
ROA(5y)11.51%
ROE(3y)35.45%
ROE(5y)39.33%
ROIC(3y)8.23%
ROIC(5y)8.18%

1.3 Margins

CE has a better Profit Margin (18.24%) than 95.24% of its industry peers.
In the last couple of years the Profit Margin of CE has remained more or less at the same level.
CE has a better Operating Margin (10.93%) than 61.90% of its industry peers.
In the last couple of years the Operating Margin of CE has declined.
CE's Gross Margin of 23.51% is in line compared to the rest of the industry. CE outperforms 45.24% of its industry peers.
CE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.93%
PM (TTM) 18.24%
GM 23.51%
OM growth 3Y-4.2%
OM growth 5Y-9.74%
PM growth 3Y-20.08%
PM growth 5Y1.21%
GM growth 3Y1.34%
GM growth 5Y-2.9%

2

2. Health

2.1 Basic Checks

CE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CE has less shares outstanding
CE has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.58, we must say that CE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.58, CE perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
CE has a debt to FCF ratio of 11.59. This is a negative value and a sign of low solvency as CE would need 11.59 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.59, CE is in line with its industry, outperforming 50.00% of the companies in the same industry.
CE has a Debt/Equity ratio of 1.56. This is a high value indicating a heavy dependency on external financing.
CE's Debt to Equity ratio of 1.56 is on the low side compared to the rest of the industry. CE is outperformed by 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 11.59
Altman-Z 1.58
ROIC/WACC0.58
WACC7.38%

2.3 Liquidity

CE has a Current Ratio of 1.28. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.28, CE is doing worse than 84.52% of the companies in the same industry.
CE has a Quick Ratio of 1.28. This is a bad value and indicates that CE is not financially healthy enough and could expect problems in meeting its short term obligations.
CE has a worse Quick ratio (0.74) than 88.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.74

5

3. Growth

3.1 Past

CE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.56%, which is quite good.
The Earnings Per Share has been decreasing by -4.16% on average over the past years.
CE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.10%.
The Revenue has been growing by 8.86% on average over the past years. This is quite good.
EPS 1Y (TTM)12.56%
EPS 3Y5.34%
EPS 5Y-4.16%
EPS Q2Q%-2.4%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y24.6%
Revenue growth 5Y8.86%
Sales Q2Q%-2.75%

3.2 Future

Based on estimates for the next years, CE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.58% on average per year.
CE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.85% yearly.
EPS Next Y-3.18%
EPS Next 2Y7.28%
EPS Next 3Y12.27%
EPS Next 5Y10.58%
Revenue Next Year-5.61%
Revenue Next 2Y-1.56%
Revenue Next 3Y0.8%
Revenue Next 5Y2.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.21, the valuation of CE can be described as reasonable.
Based on the Price/Earnings ratio, CE is valued cheaply inside the industry as 96.43% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.96. CE is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 7.31, which indicates a rather cheap valuation of CE.
Based on the Price/Forward Earnings ratio, CE is valued cheaper than 96.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, CE is valued rather cheaply.
Industry RankSector Rank
PE 8.21
Fwd PE 7.31

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CE is valued a bit cheaper than the industry average as 63.10% of the companies are valued more expensively.
CE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CE is cheaper than 94.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.28
EV/EBITDA 10.06

4.3 Compensation for Growth

CE has a very decent profitability rating, which may justify a higher PE ratio.
CE's earnings are expected to grow with 12.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.28%
EPS Next 3Y12.27%

7

5. Dividend

5.1 Amount

CE has a Yearly Dividend Yield of 3.79%. Purely for dividend investing, there may be better candidates out there.
The stock price of CE dropped by -43.17% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.95, CE pays a better dividend. On top of this CE pays more dividend than 85.71% of the companies listed in the same industry.
CE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.23.
Industry RankSector Rank
Dividend Yield 3.79%

5.2 History

The dividend of CE has a limited annual growth rate of 5.80%.
CE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CE pays out 15.95% of its income as dividend. This is a sustainable payout ratio.
The dividend of CE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP15.95%
EPS Next 2Y7.28%
EPS Next 3Y12.27%

CELANESE CORP

NYSE:CE (11/21/2024, 5:05:00 PM)

After market: 75 0 (0%)

75

+2.1 (+2.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.19B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.79%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.21
Fwd PE 7.31
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.46%
ROE 26.86%
ROCE
ROIC
ROICexc
ROICexgc
OM 10.93%
PM (TTM) 18.24%
GM 23.51%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.28
Quick Ratio 0.74
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)12.56%
EPS 3Y5.34%
EPS 5Y
EPS Q2Q%
EPS Next Y-3.18%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.1%
Revenue growth 3Y24.6%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y